Preclinical News and Research

RSS
Calistoga to feature data on CAL-101 inhibitor for hematologic malignancies at ASH Annual Meeting

Calistoga to feature data on CAL-101 inhibitor for hematologic malignancies at ASH Annual Meeting

Zalicus to highlight A2A agonist oncology programs at ASH Annual Meeting

Zalicus to highlight A2A agonist oncology programs at ASH Annual Meeting

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

JAK3 pathway highlighted as leukemia target

JAK3 pathway highlighted as leukemia target

Personalized oncology requires new paradigm for drug development, experts say

Personalized oncology requires new paradigm for drug development, experts say

Neptune, Acasti completes preclinical program comparing CaPre with Lovaza

Neptune, Acasti completes preclinical program comparing CaPre with Lovaza

XenoPort receives grant from Michael J. Fox Foundation to support Parkinson's disease therapies

XenoPort receives grant from Michael J. Fox Foundation to support Parkinson's disease therapies

BioAlliance presents AMEP preclinical, phase I clinical results for melanoma at Electrochemotherapy Meeting

BioAlliance presents AMEP preclinical, phase I clinical results for melanoma at Electrochemotherapy Meeting

Evotec to collaborate with Merck on neurological disease drug discovery program

Evotec to collaborate with Merck on neurological disease drug discovery program

Researcher develops new method that causes cancer cells to self-destruct

Researcher develops new method that causes cancer cells to self-destruct

Breakthrough with mutant gene that causes familial ALS

Breakthrough with mutant gene that causes familial ALS

HIV drugs lead to insulin resistance

HIV drugs lead to insulin resistance

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

S*BIO begins SB1317 Phase 1 clinical trial in patients with advanced/refractory hematologic malignancies

S*BIO begins SB1317 Phase 1 clinical trial in patients with advanced/refractory hematologic malignancies

Stealth Peptides introduces Bendavia clinical candidate at AHA Scientific Sessions

Stealth Peptides introduces Bendavia clinical candidate at AHA Scientific Sessions

ImmunGene awarded $244,479 therapeutic discovery project grant under PPACA 2010

ImmunGene awarded $244,479 therapeutic discovery project grant under PPACA 2010

Convergence enters drug discovery collaboration with Selcia for chronic pain treatment

Convergence enters drug discovery collaboration with Selcia for chronic pain treatment

Bardoxolone methyl treatment may reduce stage of CKD, improve eGFR in kidney function

Bardoxolone methyl treatment may reduce stage of CKD, improve eGFR in kidney function

Cascade reaffirms position on non-invasive detection of melanoma by SkinSpect device

Cascade reaffirms position on non-invasive detection of melanoma by SkinSpect device

Researchers develop medical model for regenerating bladders using stem cells

Researchers develop medical model for regenerating bladders using stem cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.